Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts
Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021